Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5115 Ulmerton Road, Clearwater, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
BOVIE MEDICAL CORP (to 1/2/2019), BOVIE MEDICAL Corp (to 1/2/2019), AN CON GENETICS INC (to 1/13/1999)
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 548 % +46.8%
Quick Ratio 86 % +20.3%
Debt-to-equity 333 % +255%
Return On Equity -154 % -175%
Return On Assets -35.9 % -23.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.8M shares +9.09%
Common Stock, Shares, Outstanding 37.8M shares +9.09%
Entity Public Float 43.1M USD -74.3%
Common Stock, Value, Issued 38K USD +8.57%
Weighted Average Number of Shares Outstanding, Basic 35.5M shares +2.66%
Weighted Average Number of Shares Outstanding, Diluted 34.6M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 48.1M USD -8.11%
Research and Development Expense 5.08M USD -6.62%
Operating Income (Loss) -18.8M USD -9.19%
Nonoperating Income (Expense) -1.03M USD -189%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.3M USD -9.52%
Income Tax Expense (Benefit) 252K USD +2.3%
Net Income (Loss) Attributable to Parent -23.5M USD -25.4%
Earnings Per Share, Basic -0.66 USD/shares -22.2%
Earnings Per Share, Diluted -0.82 USD/shares -74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31.7M USD -27.3%
Accounts Receivable, after Allowance for Credit Loss, Current 15.5M USD +10.4%
Inventory, Net 7.56M USD -23.8%
Assets, Current 56.4M USD -19.8%
Property, Plant and Equipment, Net 1.99M USD +3.76%
Operating Lease, Right-of-Use Asset 4.7M USD -8.89%
Other Assets, Noncurrent 1.66M USD -3.93%
Assets 64.8M USD -18.2%
Accounts Payable, Current 2.62M USD -3.58%
Employee-related Liabilities, Current 1.28M USD
Accrued Liabilities, Current 7.75M USD -19.8%
Contract with Customer, Liability, Current 515K USD -51.1%
Liabilities, Current 10.7M USD -15.8%
Contract with Customer, Liability, Noncurrent 1.12M USD -10.3%
Operating Lease, Liability, Noncurrent 4.48M USD -8.44%
Other Liabilities, Noncurrent 259K USD +30.8%
Liabilities 50.5M USD -3.46%
Retained Earnings (Accumulated Deficit) -77.9M USD -43.1%
Stockholders' Equity Attributable to Parent 14.2M USD -46.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.3M USD -46.8%
Liabilities and Equity 64.8M USD -18.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.34M USD -237%
Net Cash Provided by (Used in) Financing Activities -5K USD -100%
Net Cash Provided by (Used in) Investing Activities -35K USD +68.2%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 37.8M shares +9.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.37M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.7M USD +76.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +117400%
Deferred Tax Assets, Valuation Allowance 20.7M USD +25.9%
Deferred Tax Assets, Gross 22.1M USD +22.3%
Operating Lease, Liability 4.82M USD -8.11%
Payments to Acquire Property, Plant, and Equipment 35K USD -68.2%
Lessee, Operating Lease, Liability, to be Paid 6.99M USD -10.3%
Property, Plant and Equipment, Gross 5.34M USD +6.04%
Operating Lease, Liability, Current 335K USD -3.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 824K USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 797K USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.17M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 852K USD +2.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 764K USD -11.2%
Additional Paid in Capital 92.1M USD +13.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 157K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 1.36M USD -14.5%
Share-based Payment Arrangement, Expense 4.01M USD -21.5%
Interest Expense 4.52M USD +479%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%